Evaluation of comparative efficacy of Kadali Kshara Pratisarana Nasya versus Apamarga Kshara Pratisarana in the management of Nasapratinaha Inferior Turbinate Hypertrophy Randomized Controlled Trial
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 76
- 试验地点
- 1
- 主要终点
- Reduce size of inferior turbinate hypertrophy
研究概览
简要总结
This study aims to evaluate and compare the efficacy of Kadali Kshara Pratisarana Nasya and Apamarga Kshara Pratisarana Nasya in managing Nasapratinaha Inferior Turbinated Hypertrophy. It is a randomized doubleblind clinical trial involving 76 patients. Both treatments are based on Ayurvedic Kshara Karma a minimally invasive alternative to surgery. Patients are assessed using TNSS DNE and X ray PNS. Kadali Kshara is hypothesized to be non-inferior to Apamarga Kshara with potentially better patient comfort. The study fills research gaps regarding comparative efficacy, standardization, and safety of these therapies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient having Nasapratinaha(ITH) will be randomly select.
- •Patients above 20 to 80 years of age will be selected.
- •Selection is irrespective of gender, religion & socio economical class.
- •Subjects willing to participate in the study and sign the written informed consent.
排除标准
- •Bleeding Disorders (Raktapitta/Nosebleeds.
- •Urdhva Raktapitta) Atrophic Rhinitis (Pootinasa) Nasal polyp Allergic Rhinitis (Vata-Kapha Pratishyaya with hypersensitivity) Nasal Septal Perforation/Ulcers (Nasa Pitta/Vrana). Children & Very Elderly Patients.
结局指标
主要结局
Reduce size of inferior turbinate hypertrophy
时间窗: 6 Weeks
次要结局
- Improvement in Total nasal symptoms score(6 Weeks)
研究者
Dr Gauri Ghate
Mahatma Gandhi Ayurved college and research center salod Hirapur Wardha